NEW YORK, Aug. 30, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
This report analyzes the worldwide markets for Fibromyalgia Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 26 companies including many key and niche players such as Boehringer Ingelheim GmbH, Chelsea Therapeutics, Inc., Claire Ellen Products, Inc., Eli Lilly and Company, Forest Laboratories, Inc., Impax Laboratories, Inc., Meda AB, Pfizer, Inc., Pierre Fabre Medicament, Synthetic Biologics, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
To order this report:
Intl: +1 805-652-2626